{"entity":{"type":"insider","cik":"0001820518","url":"/insider/0001820518","json_url":"/insider/0001820518.json","name":"Shaw Christine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2020-08-26","last":"2021-03-08","span_basis":"filed_date"},"name_variants":[{"name":"Shaw Christine","source":"filing","n_filings":9,"first_seen":"2020-08-26","last_seen":"2021-03-08"}],"transactions":[{"id":5449359,"accession":"0001487371-21-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-21-000136","line_url":"/filing/0001487371-21-000136#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":274.0,"shares_display":"274","price_per_share":18.56,"price_display":"18.56","price_state":"stated","total_value":5085.44,"total_display":"5,085.44","total_whole":"5,085","shares_owned_after":102196.0,"shares_owned_after_display":"102,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":4477671,"accession":"0001487371-21-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-21-000123","line_url":"/filing/0001487371-21-000123#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3151.0,"shares_display":"3,151","price_per_share":17.03,"price_display":"17.03","price_state":"stated","total_value":53661.53,"total_display":"53,661.53","total_whole":"53,662","shares_owned_after":102470.0,"shares_owned_after_display":"102,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-26","filed_date":"2021-03-01","scope":"insider"},{"id":5104760,"accession":"0001487371-21-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001487371-21-000108","line_url":"/filing/0001487371-21-000108#line-2","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":259.0,"shares_display":"259","price_per_share":19.12,"price_display":"19.12","price_state":"stated","total_value":4952.08,"total_display":"4,952.08","total_whole":"4,952","shares_owned_after":105621.0,"shares_owned_after_display":"105,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-24","filed_date":"2021-02-25","scope":"insider"},{"id":5104755,"accession":"0001487371-21-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-21-000108","line_url":"/filing/0001487371-21-000108#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166.0,"shares_display":"166","price_per_share":19.35,"price_display":"19.35","price_state":"stated","total_value":3212.1,"total_display":"3,212.10","total_whole":"3,212","shares_owned_after":105880.0,"shares_owned_after_display":"105,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-25","scope":"insider"},{"id":4788989,"accession":"0001487371-21-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-21-000036","line_url":"/filing/0001487371-21-000036#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81.0,"shares_display":"81","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":1138.86,"total_display":"1,138.86","total_whole":"1,139","shares_owned_after":79796.0,"shares_owned_after_display":"79,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-29","scope":"insider"},{"id":2200234,"accession":"0001487371-20-000372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-20-000372","line_url":"/filing/0001487371-20-000372#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":274.0,"shares_display":"274","price_per_share":13.97,"price_display":"13.97","price_state":"stated","total_value":3827.78,"total_display":"3,827.78","total_whole":"3,828","shares_owned_after":79877.0,"shares_owned_after_display":"79,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-09","scope":"insider"},{"id":2363939,"accession":"0001487371-20-000365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-20-000365","line_url":"/filing/0001487371-20-000365#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":355.0,"shares_display":"355","price_per_share":13.17,"price_display":"13.17","price_state":"stated","total_value":4675.35,"total_display":"4,675.35","total_whole":"4,675","shares_owned_after":79291.0,"shares_owned_after_display":"79,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-24","filed_date":"2020-11-25","scope":"insider"},{"id":2758584,"accession":"0001487371-20-000323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-20-000323","line_url":"/filing/0001487371-20-000323#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68.0,"shares_display":"68","price_per_share":11.34,"price_display":"11.34","price_state":"stated","total_value":771.12,"total_display":"771.12","total_whole":"771","shares_owned_after":79646.0,"shares_owned_after_display":"79,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-27","filed_date":"2020-10-29","scope":"insider"},{"id":2610226,"accession":"0001487371-20-000293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-20-000293","line_url":"/filing/0001487371-20-000293#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":285.0,"shares_display":"285","price_per_share":11.02,"price_display":"11.02","price_state":"stated","total_value":3140.7,"total_display":"3,140.70","total_whole":"3,141","shares_owned_after":79714.0,"shares_owned_after_display":"79,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2363934,"accession":"0001487371-20-000277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-20-000277","line_url":"/filing/0001487371-20-000277#line-1","is_derivative":false,"issuer_cik":"0001487371","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001487371","owner_cik":"0001820518","owner_name":"Shaw Christine","owner_display_name":"Shaw Christine","owner_url":"/insider/0001820518","role":"Officer (VP, Assay Development)","role_mark":"O","role_mark_label":"Officer (VP, Assay Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Assay Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379.0,"shares_display":"379","price_per_share":14.14,"price_display":"14.14","price_state":"stated","total_value":5359.06,"total_display":"5,359.06","total_whole":"5,359","shares_owned_after":79999.0,"shares_owned_after_display":"79,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-25","filed_date":"2020-08-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001487371","name":"GenMark Diagnostics, Inc.","url":"/issuer/0001487371","role":"Officer (VP, Assay Development)","n_filings":9,"first_seen":"2020-08-26","last_seen":"2021-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001820518","retrieved_at":"2026-08-27T12:20:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}